Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT02969161 |
Date of registration:
|
17/11/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Safe Generations Plus: Swaziland PMTCT LTF Study
SG+ |
Scientific title:
|
Safe Generations Plus: Mother Infant Retention Across the Option B-plus Cascade |
Date of first enrolment:
|
March 2016 |
Target sample size:
|
616 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02969161 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Swaziland
| | | | | | | |
Contacts
|
Name:
|
Elaine Abrams, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
ICAP at Columbia University |
|
Name:
|
Averie Gachuhi, MSc |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
ICAP at Columbia University |
|
Name:
|
William Reidy, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
ICAP at Columbia University |
|
Name:
|
Harriet Nuwagaba-Biribonwoha, MBChB, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
ICAP at Columbia University |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Mothers and their infants who were enrolled in PMTCT at Safe Generations study sites
after the sites transitioned to Option B+.
- Determined to be LTF per the Safe Generations study protocol (i.e., have not attended
a clinic visit in the 90 days prior to their 6-month postpartum appointment and are
not known to be dead or transferred out, according to clinical visit data abstracted
to the Safe Generations study database).
Exclusion Criteria:
- Mothers that are not a PMTCT client.
Age minimum:
1 Year
Age maximum:
50 Years
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
HIV (Human Immunodeficiency Virus)
|
Primary Outcome(s)
|
Proportion of patients who are retained in care
[Time Frame: Up to 24 months]
|
Secondary Outcome(s)
|
Proportion of patients who are in care at another facility
[Time Frame: Up to 24 months]
|
Proportion of patients who have disengaged from care entirely
[Time Frame: Up to 24 months]
|
Proportion of patients who have died
[Time Frame: Up to 24 months]
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|